EVALUATING EFFICACY, SAFETY AND PHARMACOKINETICS AFTER SWITCHING FROM INFLIXIMAB ORIGINATOR TO BIOSIMILAR CT-P13: RESULTS FROM A LARGE TERTIARY REFERRAL CENTER

Michiel Bronswijk  1     Annick Moens  2     Matthias Lenfant  1     Griet Compernolle  2     Gert Van Assche  1     Severine Vermeire  1     Ann Gils  2     Marc Ferrante  1    
1 University Hospitals Leuven,Leuven,Belgium
2 KU Leuven,Leuven,Belgium

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing